Teva Names New CEO

Sep 12, 2017

Bloomberg

Teva Pharmaceuticals has named Kaare Schultz as its new chief executive officer, ending a seven-month search.

Schultz, previously the the CEO of H. Lundbeck, will move to Israel and be based at Teva’s headquarters in Petach Tikva. He will replace Yitzhak Peterburg, who has been the acting CEO since February.

Former Teva leader, Erez Vigodman, resigned in February, as Teva struggled with a a series of costly missteps and controversies.

Read the Bloomberg coverage

 

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments